- Sku:
- Vendor: Bravecto
Topical Solution for Cats, 2.6-6.2 lbs, (Green Box), 2 Doses (24-wks. supply)
Short content about your product.
Short content about your product.
Icons are optional
USE RICH TEXT EDITOR
And big icons to highlight the product sale point
- Fast-acting, safe and easy treatment
- BRAVECTO Topical lasts nearly 3X longer than other monthly treatments
- Up to 12 weeks* of flea & tick protection with just 1 dose!
- Easy to use non-spill, Twist’n’Use applicator. Do not give orally.
- Available in three sizes based on your cat's weight
- Did you know.. indoor cats can get fleas and ticks too?!
- Fast-acting, safe and easy treatment
- BRAVECTO Topical lasts nearly 3X longer than other monthly treatments
- Up to 12 weeks* of flea & tick protection with just 1 dose!
- Easy to use non-spill, Twist’n’Use applicator. Do not give orally.
- Available in three sizes based on your cat's weight
- Did you know.. indoor cats can get fleas and ticks too?!
BRAVECTO (fluralaner topical solution) for Cats is the first and only U.S. flea and tick product that provides protection against the Asian longhorned tick and kills 100% of fleas within 8 hours. Vet-recommended and FDA-approved, just one dose provides 12 weeks of protection. Its no secret that cats aren't a fan of monthly treatments so reduce the stress of treating your cat and apply BRAVECTO once every 12 weeks!IMPORTANT SAFETY INFORMATION:BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats has not been shown to be effective for 12-weeks' duration in kittens less than 6 months of age. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion.The safety of BRAVECTO Topical Solution for Cats has not been established in breeding, pregnant and lactating cats. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.
We directly source prescription medications from manufacturers and wholesale distributors registered with the FDA and licensed by applicable state boards. Guaranteed genuine, and where applicable, backed by the manufacturer.
| Item Number | 295238 |
|---|---|
| Generic Name | Fluralaner |
| Common Brand Name(s) | Bravecto |
| For Use With | Cats |
| Administration Form | Topical |
| Usage | Prevention, Treatment |
| Repels or Prevents | Fleas |
| Kills or Treats | Fleas, Ticks |
| Lifestage | All Lifestages, Adult |
| Breed Size | Extra Small Breeds |
| Product Form | Solution |
| Strength | 112.5 mg Fluralaner |
| Health Condition | Fleas, Ticks |
| Drug Type | Parasiticide |
Bravecto kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of black-legged tick and Asian longhorned tick infestations for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater. Bravecto is also indicated for the treatment and control of American dog tick infestations for 8 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater.
The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions.
BRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.
This item is excluded from the first-time Autoship promotion.
Active Ingredients: 112.5 mg Fluralaner.
Bravecto should be administered topically as a single dose every 12 weeks according to the Dosage Schedule below to provide a minimum dose of 18.2 mg/lb (40 mg/kg) body weight.
Bravecto may be administered every 8 weeks in case of potential exposure to Dermacentor variabilis ticks.
Do not store above 77°F. Store in the original package in order to protect from moisture. The pouch should only be opened immediately prior to use.
Add an additional description to your products. You may set the same content for all products.
Ex: Shipping and return policies, size guides, and other common questions.
Or you may link a dynamic source to show product fields like vendor or custom product meta fields.
Ex: Ingredients, nutritional info, additional features and other unique per-product data.
Have a question?
Topical Solution for Cats, 2.6-6.2 lbs, (Green Box), 2 Doses (24-wks. supply)
